Novel therapeutic strategies for patients with triple-negative breast cancer

被引:21
|
作者
Zhang, Jun-Fei [1 ]
Liu, Jia [1 ,2 ]
Wang, Yu [1 ,2 ]
Zhang, Bin [1 ,2 ]
机构
[1] Inner Mongolia Univ Nationalities, Affiliated Hosp, Tongliao, Inner Mongolia, Peoples R China
[2] Inner Mongolia Univ Nationalities, Med Chem & Pharmacol Inst, 1742 Holin He St, Tongliao 028007, Inner Mongolia, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2016年 / 9卷
基金
中国国家自然科学基金;
关键词
therapeutic strategies; TNBC; targeted agents; TUMOR-INFILTRATING LYMPHOCYTES; GROWTH-FACTOR RECEPTOR; PATHOLOGICAL COMPLETE RESPONSE; NEOADJUVANT CHEMOTHERAPY; AFRICAN-AMERICAN; PHASE-II; CARBOPLATIN; PACLITAXEL; INIPARIB; SURVIVAL;
D O I
10.2147/OTT.S105716
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Triple-negative breast cancer (TNBC) represents a very heterogeneous group of breast diseases. Currently, the backbone of therapy for TNBC is mainly chemotherapy as there are no effective specific targeted agents approved to treat TNBC. Despite initial responses to chemotherapy, resistance frequently and rapidly develops and metastatic TNBC has a poor prognosis. Therefore, new targeted strategies are, accordingly, urgently needed. This article discusses the recent developments in targeted agents explored for TNBC, aiming to offer novel therapeutic strategies that can potentially assist in designing personalized therapeutics in the future as well as provide the basis for further research in an attempt to target TNBC.
引用
收藏
页码:6519 / 6528
页数:10
相关论文
共 50 条
  • [1] Novel therapeutic strategies in the treatment of triple-negative breast cancer
    Oualla, Karima
    El-Zawahry, Heba M.
    Arun, Banu
    Reuben, James M.
    Woodward, Wendy A.
    El-Din, Heba Gamal
    Lim, Bora
    Mellas, Nawfel
    Ueno, Naoto T.
    Fouad, Tamer M.
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (07) : 493 - 511
  • [2] Therapeutic Strategies in Triple-Negative Breast Cancer
    Paradiso, Angelo
    Singer, Christian F.
    [J]. BREAST CARE, 2017, 12 (01) : 6 - 7
  • [3] Therapeutic Strategies for Triple-Negative Breast Cancer
    Tan, Antoinette R.
    Swain, Sandra M.
    [J]. CANCER JOURNAL, 2008, 14 (06): : 343 - 351
  • [4] Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
    Li, Ying
    Zhan, Zhijun
    Yin, Xuemin
    Fu, Shujun
    Deng, Xiyun
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] New Therapeutic Strategies for Triple-Negative Breast Cancer
    Szekely, Borbala
    Silber, Andrea L. M.
    Pusztai, Lajos
    [J]. ONCOLOGY-NEW YORK, 2017, 31 : 13 - 20
  • [6] New Therapeutic Strategies for Triple-Negative Breast Cancer
    Szekely, Borbala
    Silber, Andrea L. M.
    Pusztai, Lajos
    [J]. ONCOLOGY-NEW YORK, 2017, 31 (02): : 130 - 137
  • [7] Investigation of novel therapeutic and diagnostic strategies for the management of triple-negative breast cancer
    Morrison, Chevaun Danielle
    Schlemann, William
    [J]. CANCER RESEARCH, 2013, 73
  • [8] Recent advances in therapeutic strategies for triple-negative breast cancer
    Li, Yun
    Zhang, Huajun
    Merkher, Yulia
    Chen, Lin
    Liu, Na
    Leonov, Sergey
    Chen, Yongheng
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [9] Molecular targets and therapeutic strategies for triple-negative breast cancer
    Yashasvi Bhat
    M. R. Thrishna
    Satarupa Banerjee
    [J]. Molecular Biology Reports, 2023, 50 : 10535 - 10577
  • [10] Molecular targets and therapeutic strategies for triple-negative breast cancer
    Bhat, Yashasvi
    Thrishna, M. R.
    Banerjee, Satarupa
    [J]. MOLECULAR BIOLOGY REPORTS, 2023, 50 (12) : 10535 - 10577